Spots Global Cancer Trial Database for macrophage mediated phagocytosis
Every month we try and update this database with for macrophage mediated phagocytosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer | NCT05467670 | Ovarian Cancer | Pembrolizumab ALX148 Doxorubicin | 18 Years - | University of Pittsburgh | |
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer | NCT05467670 | Ovarian Cancer | Pembrolizumab ALX148 Doxorubicin | 18 Years - | University of Pittsburgh |